Downloadable Resources

Downloadable Voucher

Free 28-day trial voucher for eligible SUTENT® (sunitinib malate) patients*

Trial Voucher

Newly prescribed patients can start therapy as soon as possible with a free 28-day trial of SUTENT (sunitinib malate) regardless of coverage status.*

Free 28-day trial voucher

*Terms and conditions apply. See below.

To utilize this voucher, the patient must have a valid prescription. There is no obligation to continue SUTENT. To continue a patient on therapy, a separate prescription must be written to be filled at the patient's participating pharmacy of choice. Patients must receive the trial voucher directly from the healthcare provider.

Terms and Conditions for Voucher Program

By enrolling in the 28-day trial voucher offer for SUTENT, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

  1. Voucher is valid for 28 days of dosing of SUTENT, not to exceed 50 mg once daily for 28 days, for new patients.
  2. No claim for reimbursement for product dispensed pursuant to this voucher may be submitted to any third-party payer, whether a private or government payer.
  3. This free trial voucher cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription.
  4. This free trial is not health insurance.
  5. Offer good only in the United States and Puerto Rico.
  6. Only patients new to SUTENT may use this voucher. By redeeming this voucher, you certify that you are not currently using SUTENT.
  7. Only 1 voucher per person may be redeemed under this program. This voucher is not transferable.
  8. Pfizer reserves the right to rescind, revoke, or amend this free trial voucher without notice.
  9. The free trial voucher expires 12/31/2018.

Additional resources

Adjuvant SUTENT Dosing Overview (pdf)

A brochure describing dosage and administration for SUTENT as adjuvant treatment for patients at high risk of recurrent RCC following nephrectomy

Click to view full SUTENT Prescribing Information

Adjuvant SUTENT Quick Reference Guide (pdf)

A brochure summarizing resources for patients receiving SUTENT as well as information on dosing and the adverse reaction profile for adjuvant SUTENT

Click to view full SUTENT Prescribing Information

SUTENT Adverse Reaction Management Tips (pdf)

A brochure with tips to help manage common adverse reactions seen in patients receiving SUTENT

Click to view full SUTENT Prescribing Information

Metastatic SUTENT Dosing Overview

A brochure describing the dosage and administration of SUTENT as treatment for patients with advanced RCC

Click to view full SUTENT Prescribing Information

Metastatic SUTENT Quick Reference Guide

A brochure summarizing resources for patients receiving SUTENT as well as information on the adverse reaction profile of SUTENT for the treatment of advanced RCC

Click to view full SUTENT Prescribing Information